A. Cinal Et Al. , "Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion," GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , vol.249, no.4, pp.513-520, 2011
Cinal, A. Et Al. 2011. Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , vol.249, no.4 , 513-520.
Cinal, A., Ziemssen, F., Bartz-Schmidt, K. U., & Gelisken, F., (2011). Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , vol.249, no.4, 513-520.
Cinal, Adnan Et Al. "Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion," GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , vol.249, no.4, 513-520, 2011
Cinal, Adnan Et Al. "Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion." GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , vol.249, no.4, pp.513-520, 2011
Cinal, A. Et Al. (2011) . "Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion." GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY , vol.249, no.4, pp.513-520.
@article{article, author={Adnan Cinal Et Al. }, title={Intravitreal bevacizumab for treatment of serous macular detachment in central retinal vein occlusion}, journal={GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY}, year=2011, pages={513-520} }